Age | Substance abuse patients | General population sample | ||||
---|---|---|---|---|---|---|
Male | Female | All | Male | Female | All | |
Number (%) of patients/respondents | ||||||
All | 118 (100.0%) | 60 (100.0%) | 178 (100.0%) | 167 (100.0%) | 233 (100.0%) | 400 (100.0%) |
< −- 20 | 18 (15.3%) | 8 (13.3%) | 26 (14.6%) | 23 (13.8%) | 35 (15.0%) | 58 (14.5%) |
21–25 | 66 (55.9%) | 36 (60.0%) | 102 (57.3%) | 40 (24.0%) | 59 (25.3%) | 99 (24.8%) |
26–35 | 34 (28.8%) | 16 (26.7%) | 50 (28.1%) | 104 (62.3%) | 139 (59.7%) | 243 (60.8%) |
EQ-5D-3L value, UK value set (SD) | ||||||
All | 0.62 (0.29) | 0.53 (0.33) | 0.59 (0.31) | 0.92 (0.14) | 0.88 (0.18) | 0.90 (0.16) |
< −- 20 | 0.71 (0.29) | 0.40 (0.39) | 0.61 (0.35) | 0.95 (0.09) | 0.87 (0.16) | 0.90 (0.14) |
21–25 | 0.59 (0.28) | 0.50 (0.32) | 0.56 (0.30) | 0.92 (0.10) | 0.91 (0.12) | 0.92 (0.12) |
26–35 | 0.61 (0.32) | 0.65 (0.30) | 0.62 (0.31) | 0.91 (0.16) | 0.86 (0.20) | 0.88 (0.18) |
EQ VAS score (SD) | ||||||
All | 61.44 (21.94) | 56.75 (20.52) | 59.86 (21.53) | 84.13 (11.78) | 84.10 (15.54) | 84.11 (14.08) |
< −- 20 | 62.22 (20.16) | 52.50 (21.88) | 59.23 (20.77) | 86.91 (10.33) | 86.37 (15.22) | 86.59 (13.40) |
21–25 | 61.21 (20.29) | 57.08 (20.26) | 59.75 (20.28) | 84.05 (10.30) | 86.25 (12.30) | 85.36 (11.53) |
26–35 | 61.47 (26.18) | 58.12 (21.52) | 60.40 (24.62) | 83.54 (12.59) | 82.62 (16.73) | 83.01 (15.07) |